AGAP2 and non-small cell lung carcinoma: Taken together, these results indicated that serum exosomal lncRNA TBILA and AGAP2-AS1 have better diagnostic efficiency for NSCLC patients, and the combination of these exosomal lncRNAs and Cyfra21-1 could improve the diagnostic efficiency.